FULVIGLEN 5 ML FULVESTRANT INJECTION

Get a Price/Quote

FULVIGLEN 5 ML FULVESTRANT INJECTION Specification

Indication
Hormone Receptor Positive Advanced Breast Cancer

Origin of Medicine
Pharmaceutical

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Liquid Injection

Salt Composition
Fulvestrant 250 mg

Drug Type
Allopathic

Ingredients
Fulvestrant

Physical Form
Injection

Function
Anti-cancer treatment

Recommended For
Breast Cancer Patients

Dosage
5 mL (250 mg) per injection

Dosage Guidelines
As directed by Physician

Suitable For
Adults

Quantity
Single Vial

Storage Instructions
Store below 30C, protect from light

Administration Route
Intramuscular Injection

Marketed By
Glenmark Pharmaceuticals Ltd.

Therapeutic Class
Endocrine therapy

Prescription Required
Yes

Product Name
FULVIGLEN 5 ML Fulvestrant Injection

Shelf Life
24 months from the date of manufacture

Appearance
Clear, colourless to pale yellow viscous liquid

Pack Size
5 mL single use vial

FULVIGLEN 5 ML FULVESTRANT INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

About FULVIGLEN 5 ML FULVESTRANT INJECTION

Fulviglen

Specifications :-

Brand Name :- FULVIGLEN
Content:- Fulvestrant
Strength:- 50 mg and 250 Mg
Form:- injection
Packing:- Pack of 1 vial
Manufactured By :- Glenmark

Note :- FULVIGLENIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Targeted Breast Cancer Therapy

FULVIGLEN 5 ML Fulvestrant Injection provides an effective solution for hormone receptor positive advanced breast cancer cases. Its targeted approach interferes with cancer cell growth, offering hope for adult patients who may not be responsive to other therapies. Administration is strictly guided by a healthcare professional, maximizing benefit and safety.

Convenient and Safe Dosage Form

Each single-use vial contains 5 mL (250 mg) of Fulvestrant, ensuring precise dosing in a convenient form. The injection is administered intramuscularly, helping maintain consistent drug levels in the bloodstream. Correct storage and handling protect drug integrity, maintaining its efficacy throughout its shelf life.

FAQs of FULVIGLEN 5 ML FULVESTRANT INJECTION:

Q: How is FULVIGLEN 5 ML Fulvestrant Injection administered?

A: FULVIGLEN 5 ML is given by intramuscular injection, typically in the buttock area, by a qualified healthcare provider in a clinical setting. Self-administration is not recommended.

Q: What is the primary benefit of using FULVIGLEN Fulvestrant Injection?

A: This medication blocks estrogen receptors in breast cancer cells, thereby slowing or stopping the progression of hormone receptor positive advanced breast cancer.

Q: When should a patient receive their Fulvestrant injection?

A: Patients receive their injections as scheduled by their physician. The timing and frequency depend on the treatment protocol recommended for each patients condition.

Q: Where should FULVIGLEN 5 ML vials be stored?

A: Store each vial below 30C and protect from light to maintain its therapeutic properties throughout the shelf life.

Q: What is the recommended usage for FULVIGLEN 5 ML Injection?

A: The recommended dosage is 5 mL (250 mg) per administration, given to adult patients with hormone receptor positive advanced breast cancer as directed by their physician.

Q: How should the medicine be disposed of after use?

A: Any remaining solution or empty vial should be discarded in accordance with local medical waste disposal procedures to ensure safety and compliance.

Q: Who should not use FULVIGLEN Fulvestrant Injection?

A: Individuals who are allergic to Fulvestrant or its excipients, or those not diagnosed with hormone receptor positive advanced breast cancer, should not use this medicine.

Tell us about your requirement